Halozyme Reports Fourth Quarter 2020 Results And Full Year 2020 Results

Go back to Halozyme Reports Fourth Quarter 2020 Results And Full Year 2020 Results
Halozyme Therapeutics, Inc. (NASDAQ: HALO) Delayed: 108.31 --0 (-0%)
Previous Close $108.31    52 Week High $18.39 
Open $108.31    52 Week Low $6.96 
Day High $108.31    P/E N/A 
Day Low $108.31    EPS $-0.58 
Volume 101